ニュートラフォル ： 女性型脱毛症
A エビデンス 複数の大規模臨床試験が一貫して有意な効果を示しています。合計2,213名の参加者を対象とした9件の研究（メタアナリシス2件、RCT 2件を含む）に基づく。9件中9件の研究で肯定的な効果が示されている。
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'haircited.com';
const params = 'ingredient\u003Dnutrafol\u0026condition\u003Dfemale\u002Dpattern\u002Dhair\u002Dloss';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
A
結論
Nutrafol is well-supported by research as a nutraceutical that may help promote hair growth and improve hair quality in women experiencing pattern hair loss.
- 9 out of 9 studies show positive effects — 100% consistency
- Includes 2 placebo-controlled RCTs and 2 meta-analyses
- Demonstrated benefits across premenopausal, perimenopausal, and postmenopausal women
- Improvements seen in both hair growth and hair fiber quality
Key Study Findings
systematic review
n=1658
Double-blind
Effects of dietary supplements on androgenetic alopecia: a systematic review and network meta-analysis.
Dose: various dietary supplements (Nutrafol, apple extract, tocotrienols, pumpkin seed oil, Cistanche/Lami
vs: Placebo
効果: None
None
Cohort Study
n=11276
416 weeks
Dietary folate intake and its association with longitudinal changes in cognition function.
Dose: 50%
vs: None
Outcome: cognitive function
効果: None
P = 0.015
対象集団: None
Observational Study
n=75
Dietary Intakes of Folate, Vitamin D and Iodine during the First Trimester of Pregnancy and …
Dose: 5 mg folic acid (higher dose for obesity)
vs: None
Outcome: Dietary and supplementary intake adequacy
効果: 96% took folic acid; 26% took 5mg dose
None
対象集団: Pregnant women with obesity (BMI>=30) in UK
review
Nutraceuticals for Androgenetic Alopecia.
Dose: Nutrafol and Viviscal (oral nutraceuticals); doses per product labeling
vs: Placebo
効果: None
None
systematic_review_meta_analysis
24 weeks
Hair regrowth treatment efficacy and resistance in androgenetic alopecia: A systematic review and continuous Bayesian …
Dose: ALRV5XR, dutasteride 0.5 mg/day, finasteride 1 mg/day, LLLT, minoxidil 2%/5%, Nutrafol, Viviscal
vs: Placebo
効果: Women 24wk: ALRV5XR 30.09, LLLT 16.62, Minoxidil 2% 12.13 THs/cm2. Men: ALRV5XR 21.03, LLLT 18.75, D
statistically significant for
Review
A landscape of micronutrient status in women through the reproductive years: Insights from seven regions …
Dose: None
vs: None
Outcome: None
効果: None
None
対象集団: None
Key Statistics
8
研究数
13009
参加者数
↔
Mixed
A
グレード
Referenced Papers
Effects of dietary supplements on androgenetic alopecia: a systematic review and network meta-analysis.
Systematic Review
Frontiers in nutrition
2025
Clinical nutrition ESPEN
2023
5 件の引用
Hair regrowth treatment efficacy and resistance in androgenetic alopecia: A systematic review and continuous Bayesian network meta-analysis.
Systematic Review
Frontiers in medicine
2022
14 件の引用
The Journal of …
2022
9 件の引用
Nutrients
2022
6 件の引用
Women's health (London, …
2020
13 件の引用
Clinical nutrition (Edinburgh, …
2014
18 件の引用
International journal of …
2006
176 件の引用
Stroke
2002
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
一般的な使用量
- hairloss:
- 4 capsules/day
上限量： Not established
研究で検討された用量
| 用量 | 期間 | 効果 | N |
|---|---|---|---|
| various dietary supplements (Nutrafol, apple extract, tocotrienols, pumpkin seed oil, Cistanche/Lami | -- | Positive | 1658 |
| 50% | 416 weeks | Mixed | 11276 |
| 5 mg folic acid (higher dose for obesity) | -- | Mixed | 75 |
| Nutrafol and Viviscal (oral nutraceuticals); doses per product labeling | -- | Positive | -- |
| ALRV5XR, dutasteride 0.5 mg/day, finasteride 1 mg/day, LLLT, minoxidil 2%/5%, Nutrafol, Viviscal | 24 weeks | Positive | -- |
| None | -- | Mixed | -- |
| 300-400 mcg DFE/day | -- | Positive | -- |
| None | -- | Mixed | -- |
推奨摂取タイミング： 4 capsules together with a meal
Safety & Side Effects
報告されている副作用
- ⚠ Mild gastrointestinal discomfort
- ⚠ Headache (possibly from ashwagandha)
- ⚠ Allergic reactions in individuals sensitive to any component
- ⚠ Potential thyroid stimulation from ashwagandha
既知の相互作用
- ● Thyroid medications (ashwagandha may affect thyroid function)
- ● Anticoagulants (curcumin and saw palmetto may increase bleeding risk)
- ● Immunosuppressants (ashwagandha may stimulate immune activity)
- ● Sedatives and anxiolytics (ashwagandha has calming properties)
耐容上限摂取量： Not established
サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。
Frequently Asked Questions
Does ニュートラフォル help with 女性型脱毛症?
Based on 8 studies with 13,009 participants, there is strong evidence from multiple clinical trials that ニュートラフォル may support 女性型脱毛症 management. Our evidence grade is A (Strong Evidence).
How much ニュートラフォル should I take for 女性型脱毛症?
Studies have used various dosages. A commonly studied range is 4 capsules/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of ニュートラフォル?
Reported side effects may include Mild gastrointestinal discomfort, Headache (possibly from ashwagandha), Allergic reactions in individuals sensitive to any component, Potential thyroid stimulation from ashwagandha. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for ニュートラフォル and 女性型脱毛症?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 8 peer-reviewed studies with 13,009 total participants. The overall direction of effect is mixed.
Related Evidence
に関する他の成分： 女性型脱毛症
ニュートラフォル 他の症状・状態について
References
- [1] Lei Zhou et al.. Front Nutr. 2025. Effects of dietary supplements on androgenetic alopecia: a systematic review and network meta-analysis. doi:10.3389/fnut.2025.1719711 PubMed
- [2] Cecília Zanin Palchetti et al.. Clin Nutr ESPEN. 2023. Dietary folate intake and its association with longitudinal changes in cognition function. doi:10.1016/j.clnesp.2023.04.013 PubMed
- [3] Peter R Feldman et al.. Front Med (Lausanne). 2022. Hair regrowth treatment efficacy and resistance in androgenetic alopecia: A systematic review and continuous Bayesian network meta-analysis. doi:10.3389/fmed.2022.998623 PubMed
- [4] Christina Ring et al.. J Clin Aesthet Dermatol. 2022. Nutraceuticals for Androgenetic Alopecia. PubMed
- [5] Kathy M Redfern et al.. Nutrients. 2022. Dietary Intakes of Folate, Vitamin D and Iodine during the First Trimester of Pregnancy and the Association between Supplement Use … doi:10.3390/nu14235135 PubMed
- [6] Mary Foong-Fong Chong et al.. Womens Health (Lond). 2020. A landscape of micronutrient status in women through the reproductive years: Insights from seven regions in Asia. doi:10.1177/1745506520973110 PubMed
- [7] Rima Obeid et al.. Clin Nutr. 2014. Critical evaluation of lowering the recommended dietary intake of folate. doi:10.1016/j.clnu.2013.12.013 PubMed
- [8] Kathleen Woolf et al.. Int J Sport Nutr Exerc Metab. 2006. B-vitamins and exercise: does exercise alter requirements? doi:10.1123/ijsnem.16.5.453 PubMed
- [9] Scott E Kasner. Stroke. 2002. Folate and the risk of stroke: fortify first and ask questions later? PubMed
FDAに関する免責事項: これらの記述は米国食品医薬品局（FDA）による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。